title: Response to Uher et al.
authors.affiliation: From the Mind and Brain Theme, South Australian Health and Medical Research Institute, and the Department of Psychiatry, Flinders University School of Medicine, Adelaide, Australia; the Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami; the Department of Psychiatry, Harbor-UCLA Medical Center, Torrance, Calif.; Medical Clinic III, Carl Gustav Carus University Hospital, Dresden University of Technology, Dresden, Germany; and the John Curtin School of Medical Research, Australian National University, Canberra, Australia.
authors.forename: Ma-Li
authors.initials: ML
authors.lastname: Wong
authors.forename: Chuanhui
authors.initials: C
authors.lastname: Dong
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Flores
authors.forename: Monika
authors.initials: M
authors.lastname: Ehrhart-Bornstein
authors.forename: Stefan
authors.initials: S
authors.lastname: Bornstein
authors.forename: Mauricio
authors.initials: M
authors.lastname: Arcos-Burgos
authors.forename: Julio
authors.initials: J
authors.lastname: Licinio
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003891:Desipramine / Q000627:therapeutic use*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017058:Mexican Americans; D020641:Polymorphism, Single Nucleotide
chemical_list: D000928:Antidepressive Agents; D019208:Brain-Derived Neurotrophic Factor; D005473:Fluoxetine; D003891:Desipramine